SELLAS Life Sciences Group Inc (SLS): The update call on its Phase 3 REGAL cli...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

SELLAS Life Sciences Group Inc (SLS)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	800
Posts	50857
Boards Moderated	1
Alias Born	12/12/2004

Re: None

Monday, 10/24/2022 2:20:39 PM

Monday, October 24, 2022 2:20:39 PM

The update call on its Phase 3 REGAL clinical trial of galinpepimut-S (GPS) in patients with acute myeloid leukemia (AML) is on November 14, 2022.

The call will be facilitated by SELLAS management, including SELLAS' President and CEO, Angelos Stergiou, MD, ScD h.c., and Senior Vice President, Clinical Development, Dragan Cicic, MD, who will be joined by leading cancer researcher, M. Yair Levy, M.D., Director of Hematologic Malignancies Research at the Baylor University Medical Center, and member of the REGAL Steering Committee. Further details regarding how to access the update call will be provided in the coming weeks.

New York Yankees and Duke Basketball

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SLS News

Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:05:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:05:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:01:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:05:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 11:04:41 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 11:03:06 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 11:02:10 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 11:01:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 11:00:13 AM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/19/2024 09:11:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:07:22 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/05/2024 09:27:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:25:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 02:05:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 09:21:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:10:53 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:10:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:10:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:07:05 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:01:36 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/01/2023 08:05:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 12:11:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 12:51:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 12:29:30 PM

More SLS News

InvestorsHub NewsWire

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow